NATERA, INC. (NTRA)
Clinical trial NCT06529822 updates: 1. completion date: 2033-03-31 → 2034-06-30 2. primary completion date: 2028-10-31 → 2030-01-31 3. enrollment: 32 → 64 participants
Clinical trial NCT06529822 updates: 1. completion date: 2033-03-31 → 2034-06-30 2. primary completion date: 2028-10-31 → 2030-01-31 3. enrollment: 32 → 64 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical